CA-19-9 - Diagnostic Kit
SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
CA 19-9 as a Marker for Gastrointestinal Cancers: A Review - M J Duffy, 1998
Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
Premium Photo | Blood sample with abnormal ca 19 9 report or tumor marker test for pancreatic cancer
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
CA 19-9 as a Serum Biomarker in Cancer | SpringerLink
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Forest plot of interfering CA 19-9 serum level characteristics. | Download Scientific Diagram
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Tumor Marker CA 19-9 for Assessing Pancreatic Cancer Response - Cancer Therapy Advisor
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
IVD Antibody Development Services for CA19-9 Marker - Creative Biolabs
Tumor marker change and response rate in patients with elevated... | Download Table
![PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a96fc01f495907ea18214fdc7db7ffd9b210d72c/2-TableI-1.png "PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar")
PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar
